Thyroid Eye Disease Clinical Trials in Beijing
2 recruitingBeijing, China
Showing 1–2 of 2 trials
Recruiting
Not Applicable
Evaluating the Efficacy and Safety of Teprotumumab N01 in Patients With Thyroid Eye Disease.
Thyroid Eye Disease
Peking University Third Hospital50 enrolled1 locationNCT07423013
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease
Thyroid Eye Disease (TED)
Zai Lab (Shanghai) Co., Ltd.99 enrolled27 locationsNCT07211776